Quantum BioPharma Ltd.

NASDAQ: QNTM · Real-Time Price · USD
17.97
-0.08 (-0.44%)
At close: Aug 22, 2025, 10:35 AM

Quantum BioPharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-27.79M -21.37M -14.92M -11.11M -8.23M -10.36M -18.23M -22.73M -28.73M -31.2M -26.7M -26.72M -25.2M -29.99M -34.01M -31.98M -38.77M -29.94M
Depreciation & Amortization
504.3K 499.7K 490K 499.42K 523.55K 1.49M 2.5M 3.54M 4.54M 4.56M 4.53M 4.47M 4.33M 4.18M 4.03M 3.91M 3.88M 3.9M
Stock-Based Compensation
832.53K 94.47K 152.21K 334.07K 394.81K 686.68K 3.84M 4.24M 4.7M 4.65M 1.53M 1.37M 1.03M 3.69M 7.44M 7.37M 12.29M 9.63M
Other Working Capital
4M 5.3M 5.26M 3.41M 2.42M 2.92M 3.29M 2.35M 2.38M 1.52M 1.52M 169.83K 418.2K 3.12M 3.28M -862.53K 3.02M 914.92K
Other Non-Cash Items
8.76M 1.02M -2.36M 279.5K -1.47M -946.51K -576.27K -701.82K 2M 1.18M -575.13K -420.95K -958.48K -863.8K -1.19M -3.71M -4.68M -2.4M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
7.19M 10.6M 9.76M 3.1M 3.63M 1.08M 1.63M -657.08K -4.63M -7.19M -7.12M -4.82M -2.39M 2.6M 2.88M 2.79M 5.1M 3.23M
Operating Cash Flow
-10.51M -9.16M -6.88M -6.89M -5.14M -8.05M -10.83M -16.3M -22.1M -27.99M -28.33M -26.1M -23.17M -20.36M -20.75M -21.53M -22.08M -19.13M
Capital Expenditures
3.00 4.82 1.64 4.14 6.27 4.84 5.29 1.19K -95.73K -101.08K -365.7K -366.88K -317.85K -312.51K -547.89K -547.89K -500K -500K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -440.08 759.88K 759.88K 759.88K 760.32K n/a n/a
Purchase of Investments
-11.91M -10.46M -7.69M -3.49M -766.58K -766.64K -744.5K -1.14M -395.5K -401.58K -401.58K -6.13K -6.08K n/a n/a n/a n/a n/a
Sales Maturities Of Investments
6.16M 6.89M 5.44M -8.37K 1.18M 443.14K 443.14K 445.33K 3.48K 4.11K 164.09K 161.89K 160.61K 159.98K n/a 45.02K 150.15K 697.1K
Other Investing Acitivies
822.64K 1.47M 1.48M 1.48M 769.78K 31.78K 31.78K 208.75K 280.43K 13.01M 12.76M 12.63M 13.29M 566.85K 816.85K 769.22K 36.87K -510.08K
Investing Cash Flow
-4.93M -2.84M -1.51M -2.75M 440.4K -292.29K -270.15K -472.57K -190.34K 12.53M 12.42M 12.67M 13.37M 659.11K 265.69K 263.07K -305.15K 220.82K
Debt Repayment
5.7M 3.79M 978.16K -3.91K 248.72K 176.17K -163.8K -213.35K -199.03K -185.55K -143.07K -93.49K -68.35K -85.27K -101.91K -478.7K -1.05M -1.01M
Common Stock Repurchased
n/a n/a n/a -6.22K -6.22K -6.22K -2.96M -2.96M -3.18M -3.41M -1.93M -1.93M -1.71M -1.47M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-662.78K -37.81K -29.15K -55.21K -109.44K -150.32K -127.08K -149.91K -133.61K -118.94K -139.56K -103.46K -80.51K -54.62K -57.42K -44.23K -37.26K -6.92M
Financial Cash Flow
13.62M 14.17M 11.62M 9.13M 2.33M 455.65K -3.12M -3.14M -3.34M -3.58M -2.07M -2.05M -1.59M -1.97M 37.82M 46.22M 54.98M 62.43M
Net Cash Flow
-1.81M 2.19M 3.24M -513.68K -2.36M -7.89M -14.22M -20.11M -25.95M -19.35M -18.28M -15.57M -11.58M -21.27M 17.73M 25.37M 33.22M 43.65M
Free Cash Flow
-10.49M -9.15M -6.88M -6.89M -5.14M -8.05M -10.83M -16.3M -22.2M -28.09M -28.7M -26.42M -23.44M -20.62M -21.25M -22.07M -22.58M -16M